SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001070081-18-000084
Filing Date
2018-12-18
Accepted
2018-12-18 08:42:35
Documents
2
Period of Report
2018-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_154514053650835.html 3  
1 FORM 3 wf-form3_154514053650835.xml 3 1676
2 POWER OF ATTORNEY - REEVE ex-24.htm EX-24 4048
  Complete submission text file 0001070081-18-000084.txt   7195
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Business Address
Reeve Emma (Reporting) CIK: 0001680329 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35969 | Film No.: 181239416